| Talea Brown, NP | |
|
2400 Poplar Ave, Suite 501, Memphis, TN 38112-3213 | |
| (901) 701-2580 | |
| (901) 260-8590 |
| Full Name | Talea Brown |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Location | 2400 Poplar Ave, Memphis, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033527213 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SP0809X | Clinical Nurse Specialist - Psychiatric/mental Health, Adult | 18989 (Tennessee) | Secondary |
| 363L00000X | Nurse Practitioner | 18989 (Tennessee) | Primary |
| Entity Name | A Minds' Way Home |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699350918 PECOS PAC ID: 8123425907 Enrollment ID: O20210921002404 |
News Archive
David H. Fater, CEO of Vicor Technologies, Inc. (OTCBB: VCRT), today announced that Colonel Leopoldo Cancio of the U.S. Army Institute of Surgical Research (USAISR) identified its PD2i as a heart rate complexity metric that will be tested on trauma patients under the new Critical Combat Care Engineering (C3E) program.
A striking new study examines how far antibodies elicited by vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), or by natural infection, can neutralize the closely related bat coronavirus (CoV) RaTG13.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today reported its unaudited financial results for the first quarter ended March 31, 2010.
One way many cancers grow resistant to treatment is by generating a web of blood vessels that are so jumbled they fail to provide adequate oxygen to the tumor. With oxygen starvation, the tumor gains a sort of cloaking device that protects it from the toxic effects of chemotherapy drugs and radiation, which are designed to seek out well-oxygenated tissue.
AMRA announced that they have entered into a unique international collaboration with Pfizer Inc. to investigate the relationship between fat and muscle distribution in the body and metabolic health, including risk factors for conditions such as obesity and diabetes.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Talea Brown, NP 364 N Parkway Ste 6, Jackson, TN 38305-2874 Ph: (713) 736-4445 | Talea Brown, NP 2400 Poplar Ave, Suite 501, Memphis, TN 38112-3213 Ph: (901) 701-2580 |
News Archive
David H. Fater, CEO of Vicor Technologies, Inc. (OTCBB: VCRT), today announced that Colonel Leopoldo Cancio of the U.S. Army Institute of Surgical Research (USAISR) identified its PD2i as a heart rate complexity metric that will be tested on trauma patients under the new Critical Combat Care Engineering (C3E) program.
A striking new study examines how far antibodies elicited by vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), or by natural infection, can neutralize the closely related bat coronavirus (CoV) RaTG13.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today reported its unaudited financial results for the first quarter ended March 31, 2010.
One way many cancers grow resistant to treatment is by generating a web of blood vessels that are so jumbled they fail to provide adequate oxygen to the tumor. With oxygen starvation, the tumor gains a sort of cloaking device that protects it from the toxic effects of chemotherapy drugs and radiation, which are designed to seek out well-oxygenated tissue.
AMRA announced that they have entered into a unique international collaboration with Pfizer Inc. to investigate the relationship between fat and muscle distribution in the body and metabolic health, including risk factors for conditions such as obesity and diabetes.
› Verified 1 days ago
Michelle L Rush, MSN, APRN, BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 880 Madison Ave, Memphis, TN 38103 Phone: 901-545-6969 Fax: 901-545-1711 | |
Mrs. Leslie Rhodes, PNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 51 N Dunlap St Ste 100, Memphis, TN 38105 Phone: 901-287-7337 Fax: 901-937-6681 | |
Gwendolyn Watson, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 201 Poplar Ave, Memphis, TN 38103 Phone: 901-545-2445 | |
Barbara A Overbey, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 825 Ridge Lake Blvd, Memphis, TN 38120 Phone: 901-685-2200 Fax: 901-259-2715 | |
Florida Allen, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3362 S 3rd St, Memphis, TN 38109 Phone: 901-701-2510 Fax: 901-260-8598 | |
Mrs. Sarah Michelle Wredling, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4066 Summer Ave, Memphis, TN 38122 Phone: 901-452-7391 | |
Teri Williams, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3530 Hickory Hill Rd, Memphis, TN 38115 Phone: 901-881-6686 |